Skip to content

Is Lisinopril recalled?

41 FDA recalls mention Lisinopril. The most recent are listed below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Lisinopril.

Class II · Moderate risk Terminated Jun 1, 2015

Lisinopril tablets, USP 5mg packaged in 10-count blisters (NDC 68084-060-11); 10 blister packs per carton (NDC 68084-060-01); Rx…

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

American Health Packaging NDC 68084-060-11 D-1226-2015

Class II · Moderate risk Terminated Apr 22, 2015

Lisinopril Tablets USP, 40 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-942-01), B) 500 Count Bottles (NDC…

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1261-2015

Class II · Moderate risk Terminated Apr 22, 2015

Lisinopril Tablets USP, 30 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-953-01) and B) 500 Count Bottles (NDC…

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1260-2015

Class II · Moderate risk Terminated Apr 22, 2015

Lisinopril Tablets USP, 20 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-941-01), B) 500 Count Bottles (NDC…

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1259-2015

Class II · Moderate risk Terminated Apr 22, 2015

Lisinopril Tablets USP, 10 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-929-01), B) 500 Count Bottles (NDC…

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1258-2015

Class II · Moderate risk Terminated Apr 22, 2015

Lisinopril Tablets USP, 5 mg Tablets,Packaged in A) 100 Count Bottles (NDC: 64679-928-01), B) 500 Count Bottles (NDC…

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1257-2015

Class II · Moderate risk Terminated Apr 22, 2015

Lisinopril Tablets USP, 2.5 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-927-01) and B) 500 Count Bottles (NDC…

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1244-2015

Class II · Moderate risk Terminated Nov 14, 2014

Lisinopril active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they…

Attix Pharmaceuticals D-766-2015

Class II · Moderate risk Terminated Jul 30, 2013

Lisinopril Tablets, USP, 2.5 mg, Rx only, packaged in a) 100-count bottles (NDC 0143-1265-01) and b) 1000-count bottles (NDC…

Reason Failed Impurities/Degradation Specifications: Out of Specification results for Individual Other Unknown Related Compounds were obtained at the 48…

West-Ward Pharmaceutical Corp. NDC 0143-1265-01 D-853-2013

Class II · Moderate risk Terminated Jul 2, 2013

LISINOPRIL Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64679092701

Reason Labeling: Label Mixup; LISINOPRIL Tablet, 2.5 mg may be potentially mislabeled as RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree…

Aidapak Services, LLC D-692-2014

Class II · Moderate risk Ongoing May 29, 2013

Lisinopril 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-749-2013

Class III · Low risk Terminated Apr 9, 2013

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130…

Reason Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

Aurobindo Pharma USA Inc NDC 65862-041-01 D-498-2013

Class II · Moderate risk Terminated Mar 11, 2013

LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP, 20 mg/25 mg, 100 (NDC 60429-046-01) and 1,000 (NDC 60429-046-10) count bottles…

Reason Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the…

Gsms NDC 60429-046-01 D-244-2013

Class III · Low risk Terminated Feb 26, 2013

Lisinopril Tablets, USP 10 mg, Rx only, 1000 count bottles, Manufactured for: Mylan Pharmaceuticals Inc ,Morgantown, WV 26505…

Reason Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with an incorrect identifier code on the embossed tablets..

Mylan Pharmaceuticals Inc. D-269-2013

Class II · Moderate risk Terminated Dec 7, 2012

Lisinopril Tablets, USP 40 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1270-01); b) 1000-count tablets per bottle…

Reason Presence of Foreign Substance: Uncharacteristic black spots identified as a food grade lubricant with trace amounts of foreign particulates and…

West-ward Pharmaceutical Corp. NDC 0143-1270-01 D-130-2013

Class II · Moderate risk Terminated Nov 30, 2012

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b)…

Reason Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.

West-ward Pharmaceutical Corp. NDC 0143-1264-01 D-132-2013